{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:31:20Z","timestamp":1784784680048,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0070842"],"award-info":[{"award-number":["NNF21OC0070842"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0070842"],"award-info":[{"award-number":["NNF21OC0070842"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0070842"],"award-info":[{"award-number":["NNF21OC0070842"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0070842"],"award-info":[{"award-number":["NNF21OC0070842"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The individual woman\u2019s risk of being diagnosed with breast cancer can now be estimated more precisely, and screening can be stratified accordingly. The risk assessment requires that women are willing to provide a blood test, additional personal information, to know their risk, and alter screening intervals. This study aimed to investigate Danish women\u2019s attitudes towards risk-stratified breast cancer screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An online, cross-sectional survey was conducted among Danish women aged 52\u201367 years. We used logistic regression analyses to assess how personal characteristics were associated with the women\u2019s attitudes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>5,001 women completed the survey (response rate 44%) of which 74% approved of risk estimation to potentially alter their screening intervals. However, only 42% would accept an extended screening interval if found to have low breast cancer risk, while 89% would accept a reduced interval if at high risk. The main determinants of these attitudes were age, education, screening participation, history of breast cancer, perceived breast cancer risk and to some extent breast cancer worry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicates that women are positive towards risk-stratified breast cancer screening. However, reservations and knowledge among subgroups of women must be carefully considered and addressed before wider implementation of risk-stratified breast cancer screening in a national program.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12083-2","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:02:21Z","timestamp":1710835341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Attitudes towards risk-stratified breast cancer screening: a population-based survey among 5,001 Danish women"],"prefix":"10.1186","volume":"24","author":[{"given":"Louise Hougaard","family":"Loft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Hj\u00f8llund","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Bigaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig Egil","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"6","key":"12083_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"9760","key":"12083_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127\u201338.","journal-title":"Lancet"},{"key":"12083_CR3","unstructured":"Regionernes Kliniske Kvalitetsudviklingsprogram. Dansk Kvalitetsdatabase for Mammografiscreening. \u00c5rsrapport 2021. 2022."},{"key":"12083_CR4","doi-asserted-by":"crossref","unstructured":"Yang X, Eriksson M, Czene K, Lee A, Leslie G, Lush M et al. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. J Med Genet. 2022.","DOI":"10.2139\/ssrn.4060776"},{"issue":"2","key":"12083_CR5","doi-asserted-by":"publisher","first-page":"e86858","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forn\u00e9 C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS ONE. 2014;9(2):e86858.","journal-title":"PLoS ONE"},{"issue":"1","key":"12083_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12885-022-09484-6","volume":"22","author":"A Roux","year":"2022","unstructured":"Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the my personal breast screening (MyPeBS) randomised clinical trial. BMC Cancer. 2022;22(1):507.","journal-title":"BMC Cancer"},{"issue":"1","key":"12083_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12885-020-07054-2","volume":"20","author":"DP French","year":"2020","unstructured":"French DP, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, et al. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420). BMC Cancer. 2020;20(1):570.","journal-title":"BMC Cancer"},{"issue":"3","key":"12083_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10549-021-06346-w","volume":"189","author":"L Esserman","year":"2021","unstructured":"Esserman L, Eklund M, Veer Lvt, Shieh Y, Tice J, Ziv E, et al. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021;189(3):593\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"12083_CR9","doi-asserted-by":"crossref","unstructured":"Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Despr\u00e9s P et al. Personalized Risk Assessment for Prevention and early detection of breast Cancer: integration and implementation (PERSPECTIVE I&I). J Pers Med. 2021;11(6).","DOI":"10.3390\/jpm11060511"},{"key":"12083_CR10","unstructured":"Committee on Health Research Ethics. Number: H-23017474. Capital Region, Denmark2023."},{"issue":"8","key":"12083_CR11","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21(8):1708\u201318.","journal-title":"Genet Med"},{"issue":"1","key":"12083_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1186\/s12885-020-07464-2","volume":"20","author":"L Rainey","year":"2020","unstructured":"Rainey L, van der Waal D, Broeders MJM. Dutch women\u2019s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers. BMC Cancer. 2020;20(1):965.","journal-title":"BMC Cancer"},{"issue":"1","key":"12083_CR13","first-page":"113","volume":"39","author":"BA Fisher","year":"2017","unstructured":"Fisher BA, Wilkinson L, Valencia A. Women\u2019s interest in a personal breast cancer risk assessment and lifestyle advice at NHS mammography screening. J Public Health. 2017;39(1):113\u201321.","journal-title":"J Public Health"},{"issue":"3","key":"12083_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0969141319883662","volume":"27","author":"A Ghanouni","year":"2020","unstructured":"Ghanouni A, Sanderson SC, Pashayan N, Renzi C, von Wagner C, Waller J. Attitudes towards risk-stratified breast cancer screening among women in England: a cross-sectional survey. J Med Screen. 2020;27(3):138\u201345.","journal-title":"J Med Screen"},{"issue":"1","key":"12083_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/0284186X.2015.1043024","volume":"55","author":"M Koitsalu","year":"2016","unstructured":"Koitsalu M, Sprangers MA, Eklund M, Czene K, Hall P, Gr\u00f6nberg H, et al. Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer. Acta Oncol (Stockholm Sweden). 2016;55(1):45\u201351.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"12083_CR16","doi-asserted-by":"crossref","unstructured":"Mbuya Bienge C, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L et al. Women\u2019s Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada. J Pers Med. 2021;11(2).","DOI":"10.3390\/jpm11020095"},{"issue":"3","key":"12083_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.breast.2015.02.001","volume":"24","author":"SF Meisel","year":"2015","unstructured":"Meisel SF, Pashayan N, Rahman B, Side L, Fraser L, Gessler S, et al. Adjusting the frequency of mammography screening on the basis of genetic risk: attitudes among women in the UK. Breast. 2015;24(3):237\u201341.","journal-title":"Breast"},{"key":"12083_CR18","unstructured":"Kvernr\u00f8d A-B, Rasmussen CH, Bigaard J, Bojesen SE, Pedersen LH. Attitudes towards risk stratified breast cancer screening in Denmark - a qualitative study. Manuscript in preparation."},{"issue":"9","key":"12083_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/bjc.2016.56","volume":"114","author":"DG Evans","year":"2016","unstructured":"Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, et al. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer. 2016;114(9):1045\u201352.","journal-title":"Br J Cancer"},{"key":"12083_CR20","unstructured":"Norstat Danmark. norstat. Accessed 2023, June 19. Available from: norstat.dk. (2023)."},{"key":"12083_CR21","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2022","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022."},{"key":"12083_CR22","unstructured":"Danmarks Statistik. Befolkningens Uddannelsesstatus. Accessed February 20. 2023. Available from: https:\/\/www.dst.dk\/da\/Statistik\/emner\/uddannelse-og-forskning\/befolkningens-uddannelsesstatus (2023)."},{"issue":"1","key":"12083_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/135910530100600104","volume":"6","author":"LD Cameron","year":"2001","unstructured":"Cameron LD, Diefenbach MA. Responses to information about Psychosocial consequences of genetic testing for breast Cancer susceptibility: influences of Cancer worry and risk perceptions. J Health Psychol. 2001;6(1):47\u201359.","journal-title":"J Health Psychol"},{"issue":"1","key":"12083_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00223980.1975.9915803","volume":"91","author":"RW Rogers","year":"1975","unstructured":"Rogers RW. A Protection Motivation Theory of Fear appeals and attitude Change1. J Psychol. 1975;91(1):93\u2013114.","journal-title":"J Psychol"},{"issue":"11","key":"12083_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","volume":"4","author":"N Pashayan","year":"2018","unstructured":"Pashayan N, Morris S, Gilbert FJ, Pharoah PDP. Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast Cancer: a life-table model. JAMA Oncol. 2018;4(11):1504\u201310.","journal-title":"JAMA Oncol"},{"issue":"5","key":"12083_CR26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/pon.5051","volume":"28","author":"L Rainey","year":"2019","unstructured":"Rainey L, Jervaeus A, Donnelly LS, Evans DG, Hammarstr\u00f6m M, Hall P, et al. Women\u2019s perceptions of personalized risk-based breast cancer screening and prevention: an international focus group study. Psychooncology. 2019;28(5):1056\u201362.","journal-title":"Psychooncology"},{"issue":"1","key":"12083_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12885-021-08347-w","volume":"21","author":"L McWilliams","year":"2021","unstructured":"McWilliams L, Woof VG, Donnelly LS, Howell A, Evans DG, French DP. Extending screening intervals for women at low risk of breast cancer: do they find it acceptable? BMC Cancer. 2021;21(1):637.","journal-title":"BMC Cancer"},{"key":"12083_CR28","doi-asserted-by":"crossref","unstructured":"Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev. 2006(4):Cd001865.","DOI":"10.1002\/14651858.CD001865.pub2"},{"key":"12083_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/1471-2407-12-518","volume":"12","author":"LF Jensen","year":"2012","unstructured":"Jensen LF, Pedersen AF, Andersen B, Vedsted P. Identifying specific non-attending groups in breast cancer screening\u2013population-based registry study of participation and socio-demography. BMC Cancer. 2012;12:518.","journal-title":"BMC Cancer"},{"issue":"7451","key":"12083_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/bmj.328.7451.1312","volume":"328","author":"PM Boynton","year":"2004","unstructured":"Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ. 2004;328(7451):1312\u20135.","journal-title":"BMJ"},{"issue":"1","key":"12083_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12913-017-2254-8","volume":"17","author":"M Hawkins","year":"2017","unstructured":"Hawkins M, Gill SD, Batterham R, Elsworth GR, Osborne RH. The health literacy questionnaire (HLQ) at the patient-clinician interface: a qualitative study of what patients and clinicians mean by their HLQ scores. BMC Health Serv Res. 2017;17(1):309.","journal-title":"BMC Health Serv Res"},{"key":"12083_CR32","unstructured":"Retsinformation. Lov om videnskabsetisk behandling af sundhedsvidenskabelige forskningsprojekter. Accessed August 17, 2023. Available from: https:\/\/www.retsinformation.dk\/eli\/lta\/2011\/593 (2023)."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12083-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:04:44Z","timestamp":1710835484000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12083-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12083"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12083-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval nor informed consent were required for this study, in accordance with the Danish Act on Research Ethics Review of Health Research Projects Sect.\u00a014 [] where it is stated that \u2018notification of questionnaire surveys and medical database research projects to the system of research ethics committee system is only required if the project involves human biological material.\u2019 This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable, since no relevant identifiable participant data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}